Inhibition of glycogen synthase kinase-3 enhances the differentiation and reduces the proliferation of adult human olfactory epithelium neural precursors

被引:18
作者
Manceur, Aziza P. [1 ,2 ]
Tseng, Michael [3 ,4 ,5 ]
Holowacz, Tamara [2 ]
Witterick, Ian [5 ,6 ]
Weksberg, Rosanna [5 ,7 ]
McCurdy, Richard D. [7 ]
Warsh, Jerry J. [3 ,4 ,5 ]
Audet, Julie [1 ,2 ]
机构
[1] Univ Toronto, IBBME, Toronto, ON, Canada
[2] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada
[3] Univ Toronto, CAMH, Lab Cellular & Mol Pathophysiol, Toronto, ON, Canada
[4] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[5] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada
[6] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5S 1A1, Canada
[7] Hosp Sick Children, Res Inst, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada
基金
加拿大健康研究院;
关键词
Stem cell; GSK-3; Olfactory mucosa; TAT(47-57); Differentiation; EMBRYONIC STEM-CELLS; NEURONAL DIFFERENTIATION; SCHIZOPHRENIC-PATIENTS; FRONTAL-CORTEX; IN-VITRO; PROGENITORS; GSK-3-BETA; LITHIUM; DISEASE; NEUROGENESIS;
D O I
10.1016/j.yexcr.2011.06.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The olfactory epithelium (OE) contains neural precursor cells which can be easily harvested from a minimally invasive nasal biopsy, making them a valuable cell source to study human neural cell lineages in health and disease. Glycogen synthase kinase-3 (GSK-3) has been implicated in the etiology and treatment of neuropsychiatric disorders and also in the regulation of murine neural precursor cell fate in vitro and in vivo. In this study, we examined the impact of decreased GSK-3 activity on the fate of adult human OE neural precursors in vitro. GSK-3 inhibition was achieved using ATP-competitive (6-bromoindirubin-3'-oxime and CHIR99021) or substrate-competitive (TAT-eIF2B) inhibitors to eliminate potential confounding effects on cell fate due to off-target kinase inhibition. GSK-3 inhibitors decreased the number of neural precursor cells in OE cell cultures through a reduction in proliferation. Decreased proliferation was not associated with a reduction in cell survival but was accompanied by a reduction in nestin expression and a substantial increase in the expression of the neuronal differentiation markers MAP1B and neurofilament (NF-M) after 10 days in culture. Taken together, these results suggest that GSK-3 inhibition promotes the early stages of neuronal differentiation in cultures of adult human neural precursors and provide insights into the mechanisms by which alterations in GSK-3 signaling affect adult human neurogenesis, a cellular process strongly suspected to play a role in the etiology of neuropsychiatric disorders. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:2086 / 2098
页数:13
相关论文
共 50 条
  • [31] Glycogen synthase kinase-3β regulates astrocytic differentiation of U87-MG human glioblastoma cells
    Yan Li
    Hui-min Lu
    Gang Li
    Guang-mei Yan
    Acta Pharmacologica Sinica, 2010, 31 : 355 - 360
  • [32] Glycogen synthase kinase-3β regulates astrocytic differentiation of U87-MG human glioblastoma cells
    Li, Yan
    Lu, Hui-min
    Li, Gang
    Yan, Guang-mei
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (03) : 355 - 360
  • [33] Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites
    Ryves, WJ
    Dajani, R
    Pearl, L
    Harwood, AJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (03) : 967 - 972
  • [34] Inhibition of glycogen synthase kinase-3β protects doparninergic neurons from MPTP toxicity
    Wang, Wenya
    Yang, Yi
    Ying, Chunyi
    Li, Wenming
    Ruan, Haolan
    Zhu, Xiaonan
    You, Yan
    Han, Yifan
    Chen, Ruzhu
    Wang, Yizheng
    Li, Mingtao
    NEUROPHARMACOLOGY, 2007, 52 (08) : 1678 - 1684
  • [35] Inactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism
    Theeuwes, W. F.
    Gosker, H. R.
    Langen, R. C. J.
    Verhees, K. J. P.
    Pansters, N. A. M.
    Schols, A. M. W. J.
    Remels, A. H. V.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (12): : 3075 - 3086
  • [36] Inhibition of proteasome and shaggy/glycogen synthase kinase-3β kinase prevents clearance of phosphorylated Tau in Drosophila
    Blard, Olivier
    Frebourg, Thierry
    Campion, Dominique
    Lecourtois, Magalie
    JOURNAL OF NEUROSCIENCE RESEARCH, 2006, 84 (05) : 1107 - 1115
  • [37] Glycogen Synthase Kinase-3 and Mammalian Target of Rapamycin Pathways Contribute to DNA Synthesis, Cell Cycle Progression, and Proliferation in Human Islets
    Liu, Hui
    Remedi, Maria S.
    Pappan, Kirk L.
    Kwon, Guim
    Rohatgi, Nidhi
    Marshall, Connie A.
    McDaniel, Michael L.
    DIABETES, 2009, 58 (03) : 663 - 672
  • [38] A Novel Glycogen Synthase Kinase-3 Inhibitor Optimized for Acute Myeloid Leukemia Differentiation Activity
    Hu, Sophia
    Ueda, Masumi
    Stetson, Lindsay
    Ignatz-Hoover, James
    Moreton, Stephen
    Chakrabarti, Amit
    Xia, Zhiqiang
    Karan, Goutam
    de Lima, Marcos
    Agrawal, Mukesh K.
    Wald, David N.
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (07) : 1485 - 1494
  • [39] Glycogen synthase kinase-3beta regulates differentiation-induced apoptosis of human neural progenitor cells
    Jaeger, Alexandra
    Baake, Jana
    Weiss, Dieter G.
    Kriehuber, Ralf
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2013, 31 (01) : 61 - 68
  • [40] The Consequences of Long-Term Glycogen Synthase Kinase-3 Inhibition on Normal and Insulin Resistant Rat Hearts
    Flepisi, T. B.
    Lochner, Amanda
    Huisamen, Barbara
    CARDIOVASCULAR DRUGS AND THERAPY, 2013, 27 (05) : 381 - 392